SCHEMBL5358796

SCHEMBL5358796

O=C1Nc2ccc(S(=O)(=O)Nc3ccc(C(F)(F)F)cc3)cc2C1=Cc1c[nH]c2ccccc12

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NTRK1 P04629 8/20 0.65
SYK P43405 3/20 0.65
RET P07949 3/20 0.55
NTRK3 Q16288 4/20 0.53
NTRK2 Q16620 4/20 0.53
PRKD3 O94806 2/20 0.53
ABL1 P00519 2/20 0.53
PDGFRB P09619 2/20 0.53
LTK P29376 2/20 0.53
KDR P35968 2/20 0.53
FLT3 P36888 2/20 0.53
CSNK1A1 P48729 2/20 0.53
CDK7 P50613 2/20 0.53
MAP2K1 Q02750 2/20 0.53
MST1R Q04912 2/20 0.53
AURKB Q96GD4 2/20 0.53
CLK4 Q9HAZ1 2/20 0.53
ALK Q9UM73 2/20 0.53
DAPK3 O43293 1/20 0.53
MAP4K4 O95819 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5368295 0.87 SYK (0.68) NTRK1SYKRETNTRK3NTRK2
SCHEMBL5469851 0.84 NTRK1 (0.68) NTRK1SYKRETNTRK3NTRK2
SCHEMBL5469847 0.84 NTRK1 (0.68) NTRK1SYKRETNTRK3NTRK2
SCHEMBL7131379 0.84 MOGAT2 (0.57) NTRK1SYKNTRK3NTRK2FLT3
SCHEMBL5366412 0.84 MOGAT2 (0.55) NTRK1SYKNTRK3NTRK2MOGAT2
SCHEMBL5361507 0.84 MOGAT2 (0.55) NTRK1SYKNTRK3NTRK2MOGAT2
SCHEMBL7138180 0.83 MOGAT2 (0.53) NTRK1SYKCDK7AURKBCDK5
SCHEMBL5357745 0.83 MOGAT2 (0.58) LRRK2MOGAT2MGAT2PRKDC
SCHEMBL8639103 0.83 NTRK1 (0.65) NTRK1SYKRETNTRK3NTRK2
SCHEMBL7133809 0.83 MOGAT2 (0.50) NTRK1SYKNTRK3NTRK2MOGAT2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7202265-B2 Indolinone combinatorial libraries and related products and methods for the treatment of disease SUGEN, INC. (US) 2007-04-10 US disclosed
US-20050197382-A1 Indolinone combinatorial libraries and related products and methods for the treatment of disease SUGEN, INC. 2005-09-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050197382-A1 Indolinone combinatorial libraries and related products and methods for the treatment of disease FRK, PTK2, DSTYK NTRK1 223/4885SYK 54/4885RET 283/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.